Clinical effectiveness of a Malaysian-manufactured CAPD product: A randomised trial.

Wen Yao MakChin Tho LeongLoke Meng OngSunita BavanandanLily MushaharBak Leong GohWong Hing SengGhazali AhmadYew Fong LiewChen Hua ChingWen Jiun LiuKorina RahmatClare Hui-Hong TanMohd Kamil AhmadWan Hasnul Halimi Wan HassanFei Sia ChanZaiha HarunChek Loong LohKok Seng TengYi Loon TyeShahnaz Shah Firdaus KhanKeng-Hee KohRafidah AbdullahLai Seong Hooi

Published in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2021)

SSL was non-inferior in peritonitis rate compared to plastic-free STS over 1 year in patients requiring CAPD. There was no difference in the delivered dialysis dose, but there was a higher rate of device defects with SSL.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
randomized controlled trial
newly diagnosed
systematic review
prognostic factors
open label